Samsung Medical Center: Coronary Artery Disease trials

The registry lists 39 Coronary Artery Disease studies with Samsung Medical Center as lead sponsor. 13 are open to participants now and 0 have results posted.

Phase 4 6No phase 33(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery DiseaseNot yet recruitingNCT07442500
• Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)RecruitingNCT07329699Not applicable
• Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.RecruitingNCT07068490
• Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated BalloonRecruitingNCT07019350Not applicable
• Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)RecruitingNCT07009418Not applicable
• Emulation of Randomized Clinical Trial in Cardiovascular DiseaseRecruitingNCT06241833
• Invasive Versus Non-invasive Approach in Symptomatic Patient With Non-High Risk Coronary Artery StenosisRecruitingNCT05799092Not applicable
• Routine Versus As-Needed Stress Testing in Asymptomatic Patients With High-Risk Coronary CalciumRecruitingNCT05796739Not applicable
• Prospective Pecutaneous Coronary Intervention RegistryRecruitingNCT05624905
• Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane OxygenatorRecruitingNCT05527717Phase 4
• GENOSS Coronary Stent Clinical TrialRecruitingNCT05444452Not applicable
• Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex LesionRecruitingNCT04014803Phase 4
• Long-term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCIRecruitingNCT03870815
• Time From PCI to Cancer Surgery and Cardiovascular and Oncologic OutcomesCompletedNCT06357000
• Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCICompletedNCT06338956
• Switching to E-cigarette After PCICompletedNCT06338761
• Nationwide Cohort Study of Antiplatelet Agents as Primary PreventionCompletedNCT06281041
• Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)Active, not recruitingNCT05369182
• Drug-Coated Balloon in Patients With High Bleeding RiskActive, not recruitingNCT05221931Not applicable
• CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4TerminatedNCT05066789Phase 4
• Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular FunctionCompletedNCT05058833
• PreDiction and Validation of Clinical CoursE of Coronary Artery DiSease With CT-Derived Non-Invasive HemodYnamic Phenotyping and Plaque Characterization (DESTINY Study)CompletedNCT04794868
• Automated Algorithm Detecting Physiologic Major Stenosis and Its Relationship With Post-PCI Clinical OutcomesCompletedNCT04304677
• Prognostic Perspective of Invasive Hyperemic and Non-Hyperemic Physiologic Indices Measured After Percutaneous Coronary InterventionCompletedNCT04265443
• Multicenter Registry for Angiography-Derived Quantitative Flow RatioCompletedNCT03791788
• Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery DiseaseActive, not recruitingNCT03381872Not applicable
• Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic PlaqueActive, not recruitingNCT03169985Phase 4
• P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldTerminatedNCT03119012Phase 4
• DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular ScaffoldWithdrawnNCT03074305Not applicable
• Rotational Atherectomy for Calcified lEsion By Smart Angioplasty Research Team (SMART-RACE)Status unknownNCT02716363Not applicable
• A Study on Improved Dynamic Myocardial Perfusion With Less Effective Radiation Dose in CT (SIMPLE CT)CompletedNCT02161081Not applicable
• Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DESStatus unknownNCT02079194Not applicable
• STRATEGY for Left Main Coronary Bifurcation Lesion IICompletedNCT01798433Not applicable
• Statin and Post-interventional Coronary Microcirculation DysfunctionStatus unknownNCT01751295Not applicable
• Graft Patency Analysis of the Right Coronary Artery SystemTerminatedNCT01559350
• Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion?Status unknownNCT00852215Phase 4
• Optimal Strategy for Side Branch Stenting in Coronary Bifurcation LesionCompletedNCT00794014Not applicable
• Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance AloneStatus unknownNCT00743899Not applicable
• The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor StentCompletedNCT00418860Not applicable